January 7, 2015 -
BIO-key International announced it has received initial purchase orders for fingerprint authentication solutions from hospitals in the states of New York, Ohio, Kentucky and California, totaling $130,000.
Representing over $400,000 in revenue in 2015, the contracts will see full roll-outs at the beginning of the first quarter and throughout the year. The names of the hospitals were not disclosed in the press release.
By providing fingerprint authentication solutions to these hospitals and others, BIO-key will effectively boost the level of security and convenience for healthcare providers as they update patient records and process Electronic Prescription of Controlled Substances.
The company’s fingerprint authentication solutions support the “meaningful use” regulations as well as adhere to compliance guidelines from the U.S. Drug Enforcement Agency and respective State Boards of Pharmacy.
Over the years, fingerprint authentication has led other authentication solutions to become the preferred authentication option in healthcare for meeting such requirements as meaningful use, EPCS, I-STOP and CPOE.
“These hospital deployments are the beginning results of our strategic efforts in the North American Healthcare Market, where we enjoy technology mandates, high barriers to competition, a well-recognized and respected brand, along with many marquee customers and partners,” said Mike DePasquale, BIO-key’s chairman and CEO.
“We’re finding that our hospital customer CIO’s face three primary challenges; security, workflow and compliance. We deliver measurable improvements in each area and are seeing a noticeable increase in healthcare demand, measured in both opportunity solicitations and gross monetary value.”